Skip to main content
Signal8
Jooss Karin profile photo

Karin Jooss

CIK: 0001754280

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

FATE THERAPEUTICS INC logo
FATE

FATE THERAPEUTICS INC

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • FATE THERAPEUTICS INC logo
    FATE

    FATE THERAPEUTICS INC

    Jun 12, 2026
    Award(A)

    Stock Option (Right to Buy)

    Direct
    87.9K shares-
  • FATE THERAPEUTICS INC logo
    FATE

    FATE THERAPEUTICS INC

    May 29, 2025
    Award(A)

    Stock Option (Right to Buy)

    Direct
    55K shares-

1-2 of 2

About Jooss Karin

Jooss Karin (SEC CIK 0001754280) files insider reports with the SEC as Director of FATE THERAPEUTICS INC (FATE).

Signal8 holds 2 ownership filings by Jooss Karin, all Form 4s, filed between May 30, 2025 and Jun 15, 2026. Those filings report 2 transactions, from May 29, 2025 to Jun 12, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Jooss Karin's filings is in SAN DIEGO, CA.

Recent filings by Jooss Karin

  • Jun 12, 2026: Grant or award of FATE derivative securities (Form 4, code A).
  • May 29, 2025: Grant or award of FATE derivative securities (Form 4, code A).

Other insiders filing for FATE THERAPEUTICS INC (FATE)

How to read Form 4 transaction codes